MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

PURPOSE: Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer. METHODS: miR-100...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :ESMO Open
Главные авторы: Petrelli, Annalisa, Bellomo, Sara Erika, Sarotto, Ivana, Kubatzki, Franziska, Sgandurra, Paola, Maggiorotto, Furio, Di Virgilio, Maria Rosaria, Ponzone, Riccardo, Geuna, Elena, Galizia, Danilo, Nuzzo, Anna Maria, Medico, Enzo, Miglio, Umberto, Berrino, Enrico, Venesio, Tiziana, Ribisi, Salvatore, Provero, Paolo, Sapino, Anna, Giordano, Silvia, Montemurro, Filippo
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7597498/
https://ncbi.nlm.nih.gov/pubmed/33122354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000937
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы